An open randomized comparative study of the transcranial magnetic stimulation (TMS) efficacy and thymoanaleptic pharmacotherapy in depression with stable nonpsychotic schizophrenic patients receiving neuroleptics
Abstract
The article presents the results of an open randomized study that examined the effectiveness of transcranial magnetic stimulation (TMS). Patients were randomized into 2 therapeutic groups. Patients of the first group underwent a course of repeated TMS of the left dorsolateral prefrontal cortex. Patients of the second group underwent adequate psychopharmacotherapy with the use of antidepressants. Analysis of the effectiveness of therapy, depending on the severity of depression, showed that TMS is more effective in treating severe depressions compared with adequate psychopharmacotherapy. It is most expedient to use this method in stable patients with prevalence of negative symptoms on the background of supporting antipsychotic therapy.
About the Authors
N. V. Maslenikov
Московский НИИ психиатрии, филиал ФГБУ «ФМИЦПН им. В. П. Сербского» Минздрава России
Russian Federation
Russian Federation
E. E. Tsukarzi
Московский НИИ психиатрии, филиал ФГБУ «ФМИЦПН им. В. П. Сербского» Минздрава России
Russian Federation
Russian Federation
S. N. Mosolov
Московский НИИ психиатрии, филиал ФГБУ «ФМИЦПН им. В. П. Сербского» Минздрава России
Russian Federation
Russian Federation
References
1. Мосолов С. Н. Клиническое применение современных антидепрессантов.- СПб.: Медицинское информационное агентство.- 1995.- С. 209-352.
2. Мосолов С. Н. Шкалы психометрической оценки симптоматики шизофрении и концепция позитивных и негативных расстройств. М 2001.
3. Пуговкина О. Д., Холмогорова А. Б., Цукарзи Э. Э., Ильин С. А., Мосолов С. Н. Динамика когнитивных функций у пациентов с резистентными депрессиями при при менении электросудорожной терапии (ЭСТ) и циклической транскраниальной магнитной стимуляцией (цТМС)//Со-циальная и клиническая психиатрия.- 2006.- № 2.- с. 47-51.
4. Addington D. E., Addington J. M. Attempted suicide and depression in schizophrenia//Acta Psychiatr. Scand.- 1992.- № 85.- Р.288-91.
5. Holtzheimer P. E., Russo J., Avery D. H. A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression//Psychopharmacol. Bull.- 2001.- № 35.- P. 149-169.
6. Kim J. H., Ann J. H., Kim M. J. The relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia// Compr. Psychiatry.- 2010.- № 51.- Р.165-70.
7. Martin R. L., Cloninger C. R., Guze S. B., Clayton P. J.: Frequency and differential diagnosis of depressive syndromes in schizophrenia//J. Clin. Psychiatry.- 1985.- №46.- Р.9-13.
8. Micallef J., Fakra E., Blin O. Use of antidepressant drugs in schizophrenic patients with depression//Encephale.- 2006,- № 32.- Р.263-269.
9. Prikryl R. et al. Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study//Schizophr. Res.- 2007.- № 95. - P. 151-157.
10. Weiner R. D., Reti I.M. Key updates in the clinical application of electroconvulsive therapy// Int. Rev. Psychiatry.- 2017. № 13.- P. 1-9.
Review
For citations:
Maslenikov N.V., Tsukarzi E.E., Mosolov S.N. An open randomized comparative study of the transcranial magnetic stimulation (TMS) efficacy and thymoanaleptic pharmacotherapy in depression with stable nonpsychotic schizophrenic patients receiving neuroleptics. Medical alphabet. 2017;3(39):28-33. (In Russ.)
Views:
365
Email this article 